道瓊斯指數
50,430.33
漲跌
+232.16+0.46%
查看 MEXC 大盤美股。本頁面將市值介於 100 億至 2,000 億美元的美國上市公司歸入大盤股,並按市值排名。可對比相關公司的市值、股價及市場表現。

今日美股市場走勢分化,道瓊斯指數漲跌幅為 +0.46%,標普 500 指數為 +1.15%,納斯達克綜合指數為 +1.90%。個股方面,638 隻上漲、4,448 隻下跌,市場整體呈現分化格局。
| # | 股票 | 52 週價格區間 | |||||
|---|---|---|---|---|---|---|---|
| 701 | 愛依斯全球電力AES | $15.03 | +0.07% | 2.70M | $10.72B | $13.28 - $17.65 | 0.05% |
| 702 | 第一地平线国家FHN | $22.69 | +0.62% | 314.73K | $10.68B | $20.76 - $26.56 | 0.03% |
| 703 | Halozyme TherapHALO | $93.69 | -2.24% | 43.89K | $10.68B | $61.23 - $134.00 | 0.00% |
| 704 | AppliedAIT | $291.95 | +1.38% | 6.69K | $10.66B | $241.58 - $374.80 | 0.01% |
| 705 | Watsco, Inc.WSO | $295.93 | -0.15% | 3.17K | $10.65B | $277.34 - $459.00 | 0.04% |
| 706 | Stifel Fin.SF | $71.01 | +0.06% | 7.19K | $10.60B | $65.40 - $89.83 | 0.02% |
| 707 | Ensign GroupENSG | $181.52 | -0.81% | 4.42K | $10.59B | $141.58 - $218.00 | 0.00% |
| 708 | AECOM TechnologyACM | $82.14 | +0.75% | 17.36K | $10.57B | $56.39 - $127.00 | 0.01% |
| 709 | EastGroup PropEGP | $195.95 | +0.17% | 6.14K | $10.54B | $174.88 - $226.71 | 0.03% |
| 710 | AvantorAVTR | $15.49 | +0.75% | 25.54K | $10.50B | $7.26 - $17.45 | 0.00% |
| 711 | OGE EnergyOGE | $50.76 | -1.17% | 7.56K | $10.49B | $41.70 - $52.16 | 0.03% |
| 712 | FigmaFIG | $17.39 | -0.24% | 276.05K | $10.40B | $16.60 - $40.28 | 0.00% |
| 713 | 福斯FLS | $81.93 | +0.22% | 20.12K | $10.39B | $63.27 - $92.41 | 0.01% |
| 714 | InnioINIO | $14.15 | +2.04% | 41.29K | $10.37B | $12.95 - $42.95 | 0.00% |
| 715 | KymeraKYMR | $121.26 | -0.33% | 13.65K | $10.35B | $63.69 - $142.92 | 0.00% |
| 716 | Allison TransmissionALSN | $125.67 | +0.60% | 3.77K | $10.32B | $79.66 - $137.62 | 0.01% |
| 717 | Onto InnovationONTO | $209.24 | +4.72% | 16.05K | $10.27B | $121.58 - $386.46 | 0.00% |
| 718 | Knight-Swift TransKNX | $62.97 | -0.31% | 9.04K | $10.25B | $41.35 - $82.86 | 0.01% |
| 719 | QIAGEN N.V.QGEN | $49.71 | +0.26% | 142.18K | $10.24B | $32.53 - $57.81 | 0.00% |
| 720 | Apogee TherapeuticsAPGE | $0.00 | 0.00% | 0 | $10.22B | $0.00 - $0.00 | 0.00% |
| 721 | Solstice Advanced MaterialsSOLS | $66.05 | +1.29% | 14.27K | $10.21B | $41.32 - $90.80 | 0.15% |
| 722 | Nova Ltd.NVMI | $320.42 | +0.67% | 11.90K | $10.18B | $266.43 - $615.99 | 0.00% |
| 723 | Wintrust Fin.WTFC | $150.75 | +0.48% | 4.96K | $10.17B | $125.53 - $167.22 | 0.02% |
| 724 | BXPBXP | $63.55 | -0.50% | 9.97K | $10.15B | $49.72 - $74.94 | 0.05% |
| 725 | 達維塔保健DVA | $161.36 | -0.28% | 4.34K | $10.15B | $101.00 - $247.49 | 0.00% |
| 726 | 柏格華納BWA | $50.35 | +1.13% | 12.95K | $10.11B | $40.73 - $78.82 | 0.01% |
| 727 | SouthState BankSSB | $102.69 | +0.61% | 8.42K | $10.11B | $85.50 - $112.20 | 0.02% |
| 728 | AlbemarleALB | $85.64 | -0.02% | 35.67K | $10.11B | $85.22 - $221.00 | 0.03% |
| 729 | Bitmine Immersion TechBMNR | $16.13 | +4.40% | 975.01K | $10.10B | $12.80 - $42.09 | 0.00% |
| 730 | LittelfuseLFUS | $397.42 | +0.23% | 9.67K | $10.10B | $233.36 - $500.57 | 0.01% |
| 731 | QorvoQRVO | $0.00 | 0.00% | 0 | $10.07B | $0.00 - $0.00 | 0.00% |
| 732 | HubSpotHUBS | $205.78 | +0.43% | 13.11K | $10.05B | $169.63 - $406.94 | 0.00% |
| 733 | Semtech CorpSMTC | $107.67 | -1.02% | 54.79K | $10.05B | $60.28 - $201.99 | 0.00% |
| 734 | Chart Industries, Inc.GTLS | $0.00 | 0.00% | 0 | $10.05B | $0.00 - $0.00 | 0.00% |
| 735 | Frontline PlcFRO | $44.98 | +1.33% | 175.55K | $10.01B | $20.47 - $59.75 | 0.00% |
| 現貨美股(RealStocks) | 代幣化美股(Tokenized Stocks) | 股票合約(Stock Futures) | |
|---|---|---|---|
| 是什麼 | 美股上市公司的真實股份(現貨美股) | 與美股/ETF 掛鉤的區塊鏈代幣 | 以 USDT 保證金進行的股價合約交易 |
| 所有權 | 是 —— 真實持股 | 否 —— 僅為合成敞口 | 否 —— 僅為衍生品敞口 |
| 股東權益 | 有(如分紅) | 無 | 無 |
| 交易時間 | 美股交易時段(盤前、正常、盤後、隔夜) | 24/7 全天候 | 支援交易對最高可達 24/7 全天候 |
| 持倉方式 | 買入並持有 | 買入並持有 | 支援多空雙向、槓桿交易 |
| 適合人群 | 追求長期持有和分紅收益的投資者 | 希望全天候獲得股票敞口、無需持有股票的交易者 | 希望通過槓桿進行投機或對沖的短線/活躍交易者 |
通過 MEXC 合作的持牌券商購買真實美股,並可按適用條件享有股息等股東權益。
覆蓋 7,000+ 隻美國上市股票及 ETF,涵蓋科技、金融、醫療、消費等多個行業。
支持 USDT 轉入及 USDT/USD 轉換,更便捷地為 RealStocks 帳戶提供資金。
以具有競爭力的交易成本參與真實美股交易,讓更多資金用於投資策略。
本頁面展示的美股價格、指數、排行榜、圖表及其他市場數據可能來自第三方數據提供商,並可能存在延遲或誤差。MEXC 提供的相關信息僅供參考和教育用途,不對其準確性或完整性作出保證。頁面內容不構成任何金融或投資建議,也不構成買賣任何證券的推薦。美股交易存在風險,歷史表現不代表未來結果,用戶應在作出投資決定前進行獨立研究。